The term Desmin activators encompasses a diverse array of chemicals with the capacity to modulate the organization and function of Desmin, an intermediate filament protein critical for maintaining cellular integrity and cytoskeletal structure. Desmin, predominantly abundant in muscle tissues, assumes a pivotal role in sarcomere organization, contributing significantly to mechanical stability and overall cellular architecture. Blebbistatin, classified as a myosin II inhibitor, exerts its impact on actin-myosin dynamics, influencing the organization and localization of Desmin within the cytoskeleton. By disrupting the contractile apparatus, Blebbistatin introduces alterations in the mechanical interplay between actin and myosin, consequently influencing the dynamics of Desmin filaments. Calyculin A, recognized as a protein phosphatase inhibitor, emerges as a chemical capable of modulating Desmin phosphorylation status and cellular dynamics. By inhibiting phosphatase activities, Calyculin A introduces modifications in the phosphorylation landscape of Desmin, influencing its structural and functional properties within the cell.
Latrunculin A, acting as an actin polymerization disruptor, indirectly impacts Desmin filament assembly and organization by interfering with the dynamic processes of actin polymerization. The destabilization of actin filaments mediated by Latrunculin A contributes to alterations in the cytoskeletal framework, influencing Desmin's interaction within this dynamic network. Jasplakinolide, recognized for its actin-stabilizing properties, impacts Desmin by influencing its interaction with the cytoskeleton. Through the stabilization of actin filaments, Jasplakinolide contributes to the structural integrity of the cytoskeleton, affecting Desmin organization and its role in cellular architecture. A23187, functioning as a calcium ionophore, introduces alterations in intracellular calcium levels, thereby modulating signaling pathways intricately involved in Desmin regulation. The impact of calcium on Desmin dynamics highlights the intricate relationship between calcium signaling and the regulatory mechanisms governing Desmin organization. H-89, identified as a PKA inhibitor, modulates the cAMP/PKA pathway, influencing Desmin phosphorylation and cellular organization.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(±)-Blebbistatin | 674289-55-5 | sc-203532B sc-203532 sc-203532A sc-203532C sc-203532D | 5 mg 10 mg 25 mg 50 mg 100 mg | $183.00 $313.00 $464.00 $942.00 $1723.00 | 7 | |
Myosin II inhibitor impacting actin-myosin dynamics, potentially influencing Desmin organization and localization within the cytoskeleton. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Protein phosphatase inhibitor, affecting phosphatase activities, potentially influencing Desmin phosphorylation status and cellular dynamics. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Actin polymerization inhibitor disrupting the actin cytoskeleton, indirectly affecting Desmin filament assembly and organization. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Stabilizes actin filaments, potentially impacting Desmin interaction with the cytoskeleton. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcium ionophore influencing intracellular calcium levels, which can modulate signaling pathways involved in Desmin regulation. | ||||||
2,3-Butanedione 2-Monoxime | 57-71-6 | sc-203774 sc-203774A sc-203774B sc-203774C | 25 g 100 g 250 g 500 g | $42.00 $78.00 $161.00 $286.00 | ||
Myosin ATPase inhibitor, influencing actomyosin interactions, which can impact Desmin organization within the cytoskeleton. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Actin polymerization inhibitor affecting the cytoskeleton, potentially influencing Desmin filament assembly and cellular dynamics. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Inhibitor of Rho-associated protein kinase (ROCK), influencing the Rho/ROCK pathway, which can affect Desmin organization and cellular structure. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
Calmodulin antagonist affecting calcium-dependent processes, potentially modulating Desmin through the regulation of calcium signaling. | ||||||
CK 666 | 442633-00-3 | sc-361151 sc-361151A | 10 mg 50 mg | $321.00 $1040.00 | 5 | |
Arp2/3 complex inhibitor impacting actin polymerization, potentially influencing Desmin organization within the cytoskeleton. | ||||||